CHICAGO--(BUSINESS WIRE)-- Allscripts Healthcare Solutions, Inc. announced today that, effective January 1, 2023, it has changed its name to Veradigm Inc. (NASDAQ: MDRX). Allscripts had been ...

The name change, effective Jan. 1, has been underway since 2022, as Allscripts worked to move its products to the new brand, according to a Jan. 3 press release from the company. All remaining ...

Allscripts Healthcare Solutions on Thursday posted a nearly 7% rise in year-over-year second-quarter revenue as it continues to refocus its business on its payer and life sciences division, Veradigm.

Veradigm, Allscripts’ payer and life sciences division, joined Boston-based Harvard Pilgrim Health Care Institute and other collaborators to continue developing the FDA’s drug safety database. The FDA ...

UPDATE: Sept. 25, 2023: Veradigm has received notice that its shares will be delisted from the Nasdaq after the health IT company failed to file required financial paperwork before the end of the ...

SOUTH SAN FRANCISCO and CHICAGO, Oct. 6, 2023 /PRNewswire/ -- FDB (First Databank, Inc.), a major provider of drug knowledge that helps healthcare professionals make precise decisions, and Veradigm ...

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX) between February 26, 2021 and ...

After shedding its hospital business segment earlier this year, health IT company Allscripts is doubling down on its strategy to grow its payers and life sciences businesses. Allscripts sold its ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Chicago-based health care technology company Veradigm ...

Veradigm Inc. said in a press release this morning that it won't meet today's deadline to file its long overdue 2022 financial reports, but it will request a hearing in order to temporarily stay ...